Herrmann J - Search Results

1

Hypertension and Prohypertensive Antineoplastic Therapies in Cancer Patients.

van Dorst DCH, Dobbin SJH, Neves KB, Herrmann J, Herrmann SM, Versmissen J, Mathijssen RHJ, Danser AHJ, Lang NN. van Dorst DCH, et al. Among authors: herrmann sm, herrmann j. Circ Res. 2021 Apr 2;128(7):1040-1061. doi: 10.1161/CIRCRESAHA.121.318051. Epub 2021 Apr 1. Circ Res. 2021. PMID: 33793337 Free PMC article. Review.

2

Evaluation and management of patients with heart disease and cancer: cardio-oncology.

Herrmann J, Lerman A, Sandhu NP, Villarraga HR, Mulvagh SL, Kohli M. Herrmann J, et al. Mayo Clin Proc. 2014 Sep;89(9):1287-306. doi: 10.1016/j.mayocp.2014.05.013. Mayo Clin Proc. 2014. PMID: 25192616 Free PMC article. Review.

3

New-onset heart failure in association with severe hypertension during trastuzumab therapy.

Herrmann J, Herrmann SM, Haddad TC. Herrmann J, et al. Among authors: herrmann sm. Mayo Clin Proc. 2014 Dec;89(12):1734-9. doi: 10.1016/j.mayocp.2014.08.011. Epub 2014 Nov 1. Mayo Clin Proc. 2014. PMID: 25441402

4

Vascular Toxicities of Cancer Therapies: The Old and the New--An Evolving Avenue.

Herrmann J, Yang EH, Iliescu CA, Cilingiroglu M, Charitakis K, Hakeem A, Toutouzas K, Leesar MA, Grines CL, Marmagkiolis K. Herrmann J, et al. Circulation. 2016 Mar 29;133(13):1272-89. doi: 10.1161/CIRCULATIONAHA.115.018347. Circulation. 2016. PMID: 27022039 Free PMC article. Review.

5

Response by Herrmann et al to Letter Regarding Article, "Vascular Toxicities of Cancer Therapies: The Old and the New-An Evolving Avenue".

Herrmann J, Yang EH, Iliescu C, Marmagkiolis K. Herrmann J, et al. Circulation. 2016 Nov 15;134(20):e466-e467. doi: 10.1161/CIRCULATIONAHA.116.024415. Circulation. 2016. PMID: 27881502 No abstract available.

6

Recent Advances in Hypertension and Cardiovascular Toxicities With Vascular Endothelial Growth Factor Inhibition.

Touyz RM, Lang NN, Herrmann J, van den Meiracker AH, Danser AHJ. Touyz RM, et al. Among authors: herrmann j. Hypertension. 2017 Aug;70(2):220-226. doi: 10.1161/HYPERTENSIONAHA.117.08856. Epub 2017 Jun 19. Hypertension. 2017. PMID: 28630211 Free PMC article. Review.

7

Vascular toxicities with VEGF inhibitor therapies-focus on hypertension and arterial thrombotic events.

Touyz RM, Herrmann SMS, Herrmann J. Touyz RM, et al. Among authors: herrmann j, herrmann sms. J Am Soc Hypertens. 2018 Jun;12(6):409-425. doi: 10.1016/j.jash.2018.03.008. Epub 2018 Mar 21. J Am Soc Hypertens. 2018. PMID: 29703600 Free PMC article. Review.

8

Programmed cell death protein 1 inhibitor treatment is associated with acute kidney injury and hypocalcemia: meta-analysis.

Manohar S, Kompotiatis P, Thongprayoon C, Cheungpasitporn W, Herrmann J, Herrmann SM. Manohar S, et al. Among authors: herrmann sm, herrmann j. Nephrol Dial Transplant. 2019 Jan 1;34(1):108-117. doi: 10.1093/ndt/gfy105. Nephrol Dial Transplant. 2019. PMID: 29762725

9

Common Vascular Toxicities of Cancer Therapies.

Herrmann J. Herrmann J. Cardiol Clin. 2019 Nov;37(4):365-384. doi: 10.1016/j.ccl.2019.07.003. Epub 2019 Aug 26. Cardiol Clin. 2019. PMID: 31587779 Free PMC article. Review.

10

Vascular toxic effects of cancer therapies.

Herrmann J. Herrmann J. Nat Rev Cardiol. 2020 Aug;17(8):503-522. doi: 10.1038/s41569-020-0347-2. Epub 2020 Mar 26. Nat Rev Cardiol. 2020. PMID: 32218531 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,038 results

Search Page